Loading…
HeartBeam, Inc. is projected to rise to $0.7492 by 2027, a +24% move from its current price of $0.605. BEAT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $0.5806 | $0.6052 | $0.6309 | +0.04% |
| Jul 15 | $0.5709 | $0.6054 | $0.6421 | +0.07% |
| Jul 16 | $0.5636 | $0.6057 | $0.6508 | +0.11% |
| Jul 17 | $0.5576 | $0.6059 | $0.6584 | +0.14% |
| Jul 18 | $0.5523 | $0.6061 | $0.6651 | +0.18% |
| Jul 19 | $0.5477 | $0.6063 | $0.6712 | +0.22% |
| Jul 20 | $0.5434 | $0.6065 | $0.677 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5434 | $0.6065 | $0.677 | +0.25% |
| Week 2 | $0.5205 | $0.6081 | $0.7103 | +0.50% |
| Week 3 | $0.5039 | $0.6096 | $0.7374 | +0.76% |
| Week 4 | $0.4905 | $0.6111 | $0.7614 | +1.01% |
| Week 5 | $0.4792 | $0.6127 | $0.7833 | +1.27% |
| Week 6 | $0.4692 | $0.6142 | $0.804 | +1.52% |
| Week 7 | $0.4604 | $0.6158 | $0.8236 | +1.78% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HeartBeam, Inc. is a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment, which consists of a credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms.
HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
HeartBeam operates in the healthcare sector, focusing on technologies that support outside-hospital cardiac care and monitoring through its ECG platform and related software ecosystem.
The description above provides a concise view of HeartBeam’s business focus and geographic base without extrapolating beyond the stated facts about its products, incorporation date, or location.
HeartBeam, Inc. (BEAT) is currently trading at $0.605 per share with a market cap of $33.58M, and it is ranked 4701 by market capitalization.
The near-term forecast for 2026 shows a min price of $0.605, an average price of $0.605, and a max of $0.8566, with a neutral sentiment and a 0% ROI, indicating little expected change on average that year.
Longer-range projections turn bullish starting in 2027, with the average price rising to $0.7488 and the max to $1.06 (ROI 23.8%), followed by continued upside through 2029 and beyond, including multi-year targets such as $1.96 average by 2050 and a max of $4.33. These figures reflect bullish sentiment across the forecast horizon.
Overall, the current price action sits amid a structured forecast that turns progressively more favorable through 2050, though the 2026 period is expected to be relatively flat on average. These are estimates and not guarantees.
A major floor 33.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 49.8% above — a clean break opens room to run.
A major ceiling 152.9% above — clearing it would confirm fresh momentum.
Key BEAT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BEAT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6442 | Sell | $0.641 | Sell |
| MA 10 | $0.6748 | Sell | $0.6654 | Sell |
| MA 20 | $0.6984 | Sell | $0.7045 | Sell |
| MA 50 | $0.8109 | Sell | $0.8188 | Sell |
| MA 100 | $1.02 | Sell | $1.00 | Sell |
| MA 200 | $1.39 | Sell | $1.24 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.86 | Neutral |
| Stoch RSI (14) | 30.11 | Neutral |
| CCI (20) | -149.68 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -11.81 | Sell |
| Bollinger %B (20,2) | 0.02 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.93 | Sell |
| Awesome (5,34) | -0.12 | Sell |
| Ultimate (7,14,28) | 18.76 | Buy |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.61 | Sell |
| ADX (14) | 25.11 | Sell |
| ATR (14) | 0.03 | Info |
The short-term technical picture is bearish, with an RSI(14) of 30 and an overall bearish sentiment.
The 30-day moving averages show SMA50 at $0.8109 and SMA200 at $1.39, creating near-term resistance above the current price. Support is identified at $0.605, with a nearby resistance at $0.906.
The 30-day price range spans from a low of $0.4601 to a high of $0.7956, illustrating limited upside momentum in the near term while still leaving a defined path for a potential rebound if buyers step in.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.605 | $0.605 | $0.8543 | 0% | Neutral | |
| $0.5676 | $0.7492 | $1.06 | +24% | Bullish | |
| $0.6087 | $0.8404 | $1.25 | +39% | Bullish | |
| $0.5732 | $0.8219 | $1.28 | +36% | Bullish | |
| $0.4978 | $0.7385 | $1.19 | +22% | Bullish | |
| $0.4908 | $0.7511 | $1.24 | +24% | Bullish | |
| $0.48 | $0.7566 | $1.29 | +25% | Bullish | |
| $0.5526 | $0.8958 | $1.56 | +48% | Bullish | |
| $0.6161 | $1.03 | $1.82 | +70% | Bullish | |
| $0.5966 | $1.02 | $1.85 | +69% | Bullish | |
| $0.6797 | $1.31 | $2.58 | +117% | Bullish | |
| $0.8814 | $1.96 | $4.32 | +224% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.605 | $0.605 | $0.7117 | +0.00% |
| August 2026 | $0.5058 | $0.6054 | $0.75 | +0.06% |
| September 2026 | $0.5167 | $0.6252 | $0.7874 | +3.27% |
| October 2026 | $0.4938 | $0.6031 | $0.7703 | -3.52% |
| November 2026 | $0.4908 | $0.6042 | $0.7805 | +0.17% |
| December 2026 | $0.5276 | $0.6543 | $0.8543 | +8.30% |
Click any year to see its month-by-month BEAT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BEAT could reach as high as $0.8543, with a base case around $0.605 and support toward $0.605 — roughly 0% from $0.605. A consolidation phase looks the most probable path here.
Expect BEAT to range from $0.5676 to $1.06 through 2027. The $0.7492 average target implies a +24% move from current prices. That is up +24% on the projected 2026 average. Momentum favours further upside here.
The BEAT price prediction for 2028 points to an average of $0.8404 (low $0.6087, high $1.25) — a potential gain of +39% on today's $0.605. Buyers look set to stay in control over this stretch.
In 2029, BEAT is projected to trade between $0.5732 and $1.28, averaging $0.8219 — a potential gain of +36% from today's $0.605. That is -2% versus the projected 2028 average. Momentum favours further upside here.
HeartBeam, Inc.'s 2030 outlook centres on $0.7385, within a $0.4978 to $1.19 range. That is -10% versus the projected 2029 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, BEAT could reach as high as $1.24, with a base case around $0.7511 and support toward $0.4908 — roughly +24% from $0.605. Momentum favours further upside here.
Expect BEAT to range from $0.48 to $1.29 through 2032. The $0.7566 average target implies a +25% move from current prices. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The BEAT price prediction for 2033 points to an average of $0.8958 (low $0.5526, high $1.56) — a potential gain of +48% on today's $0.605. Momentum favours further upside here.
In 2034, BEAT is projected to trade between $0.6161 and $1.82, averaging $1.03 — a potential gain of +70% from today's $0.605. That is up +15% on the projected 2033 average. Buyers look set to stay in control over this stretch.
HeartBeam, Inc.'s 2035 outlook centres on $1.02, within a $0.5966 to $1.85 range. That is -1% versus the projected 2034 average. That marks a +69% change versus current levels. Momentum favours further upside here.
By 2040, BEAT could reach as high as $2.58, with a base case around $1.31 and support toward $0.6797 — roughly +117% from $0.605. Buyers look set to stay in control over this stretch.
Expect BEAT to range from $0.8814 to $4.32 through 2050. The $1.96 average target implies a +224% move from current prices. That is up +49% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BEAT today (≈ 1,652.892562 BEAT) could be worth
$3,237.53
+$2,237.53 (+224%) by 2050 · US Dollar
Based on the average projected BEAT price of $1.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BEATwould be worth at today's price.
$1,000 invested in BEAT on Jul 10, 2025 (≈ 787.401587 BEAT) would be worth
$476.38
-$523.62 (-52.4%) today · 0.48× · US Dollar
Based on a BEAT entry price of $1.27 vs. today's $0.605.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.72 | $840.28 | -16.0% |
| 1 month ago | $0.764 | $791.88 | -20.8% |
| 3 months ago | $1.15 | $526.09 | -47.4% |
| 6 months ago | $2.56 | $236.33 | -76.4% |
| 1 year ago | $1.27 | $476.38 | -52.4% |
| All time (4.7y) ago | $4.69 | $129 | -87.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BEAT forecast.
Our base-case forecast reaches $1.20 around 2040.
Implied market cap at $1.20: $66.61M
The multi-year forecast reflects a bullish path after 2026. In 2027, the price is projected to average $0.7488 with a max of $1.06 and a min of $0.5672 (ROI 23.8%), followed by continued upside in 2028 (avg $0.8402, max $1.25, ROI 38.9%). By 2029, the average price is seen at $0.8228 with a max of $1.28 (ROI 36%).
From 2030 onward, the forecast remains bullish, with 2030 avg $0.7373, 2031 avg $0.7515, and 2032 avg $0.7577, each with max values above $1.20 and ROIs around 21–25%. The trajectory accelerates later, with 2033 avg $0.8944 and max $1.56 (ROI 47.8%), 2034 avg $1.03 and max $1.82 (ROI 69.8%), and 2035 avg $1.02 with max $1.85 (ROI 68.8%).
The most pronounced upside appears in the distant horizon: 2040 is forecast at avg $1.31 (min $0.68, max $2.58; ROI 117.2%), and 2050 at avg $1.96 (min $0.8833, max $4.33; ROI 224.4%). Throughout this span, sentiment is bullish, reflecting an expectation of higher average prices and larger potential ROIs as time extends. These are estimates, not guarantees.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $0.7373 with a max of $1.19 and a min of $0.497, and an estimated ROI of 21.9%. The sentiment for that year is bullish.
The forecast turns bullish from 2027 onward with rising average prices (e.g., $0.7488 in 2027, $0.8402 in 2028, and higher thereafter) and positive ROIs (up to 224.4% by 2050). The 2026 year is neutral with an average of $0.605 and 0% ROI.
Yes. Several years in the forecast show max prices above $1.00, including 2027 (max $1.06), 2033 (max $1.56), 2034 (max $1.82), and 2040 (max $2.58), among others.
The 2040 forecast targets an average price of $1.31, with a min of $0.68 and a max of $2.58, and an estimated ROI of 117.2% while maintaining a bullish sentiment.
The near-term outlook shows bearish sentiment and a lower RSI (14) of 30, with notable volatility at 80% annualized. This implies potential downside risk in the short term, even as longer-term projections trend bullish.
HeartBeam, Inc. Community Discussion
0Share your HeartBeam, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.